DrugPatentWatch Database Preview

Details for Patent: 6,916,941

« Back to Dashboard

Which drugs does patent 6,916,941 protect, and when does it expire?

Patent 6,916,941 protects LEXAPRO and is included in one NDA.

Protection for LEXAPRO has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-one patent family members in thirty-eight countries.

Summary for Patent: 6,916,941

Title:	Crystalline composition containing escitalopram
Abstract:	Crystalline particles of escitalopram oxalate with a particle size of at least 40 .mu.m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.
Inventor(s):	Christensen; Troels Volsgaard (Holb.ae butted.k, DK), Liljegren; Ken (V.ae butted.rl.o slashed.se, DK), Elema; Michiel Onne (K.o slashed.bnhavn .O slashed., DK), Andresen; Lene (R.o slashed.dovre, DK), Mahashabde; Shashank (Kendall Park, NJ), Assenza; Sebastian P. (Fort Salonga, NY)
Assignee:	H. Lundbeck A/S (Valby-Copenhagen, DK)
Application Number:	10/403,453
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,916,941
Patent Claim Types: see list of patent claims	Compound; Use; Formulation; Dosage form; Composition;

Drugs Protected by US Patent 6,916,941

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Allergan Sales Llc	LEXAPRO	escitalopram oxalate	TABLET;ORAL	021323-001	Aug 14, 2002	AB	RX	Yes	No					Y
Allergan Sales Llc	LEXAPRO	escitalopram oxalate	TABLET;ORAL	021323-002	Aug 14, 2002	AB	RX	Yes	No					Y
Allergan Sales Llc	LEXAPRO	escitalopram oxalate	TABLET;ORAL	021323-003	Aug 14, 2002	AB	RX	Yes	Yes					Y

Foreign Priority and PCT Information for Patent: 6,916,941

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Denmark	PA 2001 01164	Jul 31, 2001

Non-Orange Book US Patents Family Members for Patent 6,916,941

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
7,420,069	Crystalline composition containing escitalopram

International Family Members for US Patent 6,916,941

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	034898
Austria	286730
Austria	352546
Australia	2002355624